☰

Mary D. Bareford, Ph.D.

Affiliations: 
2012 Biochemistry Virginia Commonwealth University, Richmond, VA, United States 
Area:
Biochemistry, Molecular Biology, Cell Biology, Oncology
Google:
"Mary Bareford"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Paul Dent grad student 2012 VCU
 (Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cruickshanks N, Roberts JL, Bareford MD, et al. (2015) Differential regulation of autophagy and cell viability by ceramide species. Cancer Biology & Therapy. 16: 733-42
Bareford MD, Hamed HA, Allegood J, et al. (2012) Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling. Cancer Biology & Therapy. 13: 793-803
Cruickshanks N, Hamed HA, Bareford MD, et al. (2012) Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1. Molecular Pharmacology. 81: 748-58
Booth LA, Cruickshanks N, Tang Y, et al. (2012) Current advances in ER stress intervention therapies Endoplasmic Reticulum Stress in Health and Disease. 2147483647: 429-445
Bareford MD, Hamed HA, Tang Y, et al. (2011) Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Autophagy. 7: 1261-2
Mitchell C, Hamed HA, Cruickshanks N, et al. (2011) Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death. Cancer Biology & Therapy. 12: 215-28
Bareford MD, Park MA, Yacoub A, et al. (2011) Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Research. 71: 4955-67
Bareford MD, Hamed HA, Park M, et al. (2011) Abstract 5390: A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels Cancer Research. 71: 5390-5390
Hamed HA, Mitchell C, Dent P, et al. (2011) Abstract 5383: Inhibition of MCL-1 in mammary and CNS tumor cells promotes cell deathin vitroandin vivo Cancer Research. 71: 5383-5383
Mitchell C, Yacoub A, Hossein H, et al. (2010) Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo. Cancer Biology & Therapy. 10: 903-17
See more...